Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
| Purity | ≥70% |
|---|---|
| Formula | C16H14N2O4 |
| Formula Wt. | 298.29 |
| Appearance | Red Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
S-enantiomer of citalopram; SERT inhibitor.
Triazolopyrazine; c-MET inhibitor.
Amide form of vitamin B3 required for productio...
NSAID; COX-1/2 inhibitor.
Octapeptide derived from activity-dependent neu...
Found in Astragalus membranaceus.
Endogenous neuropeptide hormone; somatostatin a...
Endogenous peptide hormone fragment, involved i...
Recombinant HIV-1 glycoprotein antigen fragment...
Aminoglycoside; protein translation inhibitor, ...
Podophyllotoxin derivative; topoisomerase II in...
EZH2 HMT inhibitor.
Caffeic acid derivative.
Induces DNA strand breakage.
Pt-based DNA cross-linker.
D-amino acid, incorporated into bacterial cell ...
ROCK1/2 inhibitor, potential RSK and p70S6K inh...
PI3K and mTOR inhibitor.
Endogenous sulfonic acid involved in Ca2+ signa...
Polyketide found in Setophoma.